BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7772761)

  • 21. [Enhanced MRI of breast cancer smaller than 3 cm].
    Ikeda Y; Narabayashi I; Yoshida S; Motohara T; Koizumi T; Ogawa K; Mieda C; Ueda E; Hirota S; Oshitani T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Nov; 51(11):1314-23. PubMed ID: 1662800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Parametrial infiltration of cervix carcinoma: diagnostic value of contrast-enhanced fat-suppressed T1-weighted SE sequences at 1.5 tesla].
    Scheidler J; Heuck A; Wencke K; Kimmig R; Müller-Lisse U; Reiser M
    Rofo; 1997 Apr; 166(4):312-6. PubMed ID: 9198495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The weighting of SE, IE and GE sequences in tumors of the head and neck].
    Wagner-Manslau C; Bauer R; van de Flierdt E; Lukas P; Clasen B; Hässler A; Pabst HW
    Rofo; 1990 Aug; 153(2):154-60. PubMed ID: 2168070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fat-suppressed MR imaging sequences in the diagnosis of liver and pancreatic neoplasms at 1.5 tesla].
    Hagspiel KD; Neidl KF; Hauser M; Duewell S; Marincek B
    Rofo; 1994 Mar; 160(3):235-42. PubMed ID: 8136477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI.
    Kim JK; Altun E; Elias J; Pamuklar E; Rivero H; Semelka RC
    J Magn Reson Imaging; 2007 Aug; 26(2):313-22. PubMed ID: 17610286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
    Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
    Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on magnetic resonance imaging of pancreatic cancer].
    Hirose Y
    Nihon Geka Hokan; 1991 Sep; 60(5):316-26. PubMed ID: 1820003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
    Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
    Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preoperative differential diagnosis of cystic adnexal tumors: double-contrast MRT].
    Reuter M; Steffens JC; Schüppler U; Muhle C; Brinkmann G; Kohl A; Weisner D; Lüttges J; Spielmann RP; Heller M
    Rofo; 1996 May; 164(5):394-400. PubMed ID: 8634400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
    Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
    Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined use of MRI and MR cholangiopancreatography and contrast enhanced dual phase 3-D MR angiography in diagnosis of pancreatic tumors: initial clinical results].
    Gaa J; Wendl K; Tesdal IK; Meier-Willersen HJ; Lehmann KJ; Böhm C; Möckel R; Richter A; Trede M; Georgi M
    Rofo; 1999 Jun; 170(6):528-33. PubMed ID: 10420901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [MR tomography in testicular processes. The significance of Gd-DTPA enhanced sequences in comparison with plain T2-weighted sequences].
    Just M; Melchior S; Grebe P; Kreitner KF; Bürger RA; Hohenfellner R; Thelen M
    Rofo; 1992 Jun; 156(6):527-31. PubMed ID: 1617172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of renal function using Gd-DTPA dynamic MR imaging].
    Furukawa A; Murata K; Morita R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Apr; 56(5):264-74. PubMed ID: 8692650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI and S-MRCP findings in patients with suspected chronic pancreatitis: correlation with endoscopic pancreatic function testing (ePFT).
    Balci NC; Smith A; Momtahen AJ; Alkaade S; Fattahi R; Tariq S; Burton F
    J Magn Reson Imaging; 2010 Mar; 31(3):601-6. PubMed ID: 20187202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
    Gehl HB; Günther RW; Klever P; Hauptmann S
    Rofo; 1993 Sep; 159(3):240-4. PubMed ID: 8397012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
    Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
    Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular complications of pancreatic transplantation: MR evaluation.
    Krebs TL; Daly B; Wong JJ; Chow CC; Bartlett ST
    Radiology; 1995 Sep; 196(3):793-8. PubMed ID: 7644645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging of the pancreas with gadolinium-DTPA.
    Chezmar JL; Nelson RC; Small WC; Bernardino ME
    Gastrointest Radiol; 1991; 16(2):139-42. PubMed ID: 2016027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.